Literature DB >> 28505287

Anti-Helicobacter pylori activity of non-living, heat-killed form of lactobacilli including Lactobacillus johnsonii No.1088.

Yuji Aiba1,2, Hiroki Ishikawa1, Masayoshi Tokunaga3, Yasuhiko Komatsu1.   

Abstract

Some strains of lactic acid bacteria are reported to inhibit the growth of Helicobacter pylori and proposed to be useful to support so-called triple therapy for H. pylori. Although most strains must be alive to exert their anti-H. pylori activity, some lactobacilli strains are effective even when dead. One possible underlying mechanism of such an activity of non-living lactobacilli is reportedly co-aggregation with H. pylori. In this study, we found that a non-living heat-killed form of Lactobacillus johnsonii No.1088 (HK-LJ88) and also that of some other lactobacilli inhibited the growth of H. pylori in vitro. Furthermore, the number of H. pylori in the infected stomach of germ-free mice was significantly decreased by the repeated oral administration of HK-LJ88. Observation by scanning electron microscopy revealed that no co-aggregation had occurred between H. pylori and HK-LJ88; instead, deformations of H. pylori (e.g. disappearance of spiral, bending of cell body, coccoid formation, degradations, etc.) appeared after incubation for 24 h with HK-LJ88. These results suggest that HK-LJ88 inhibited H. pylori activity probably not by co-aggregation but by some unknown mechanism involving HK-LJ88's cell surface molecules and that even non-living lactobacilli are possibly useful to support H. pylori eradication therapy. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Lactobacillus johnsonii; anti-Helicobacter pylori activity; germ-free mice; lactic acid bacterium; non-living heat-killed form; scanning electron microscopy

Mesh:

Year:  2017        PMID: 28505287     DOI: 10.1093/femsle/fnx102

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Consumption of a Gelatin Supplemented with the Probiotic Strain Limosilactobacillus fermentum UCO-979C Prevents Helicobacter pylori Infection in a Young Adult Population Achieved.

Authors:  Cristian Parra-Sepúlveda; Kimberly Sánchez-Alonzo; Joaquín Olivares-Muñoz; Cristian Gutiérrez-Zamorano; Carlos T Smith; Romina I Carvajal; Katia Sáez-Carrillo; Carlos González; Apolinaria García-Cancino
Journal:  Foods       Date:  2022-06-07

2.  Lactobacillus delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway.

Authors:  Fernanda Alvarenga Lima Barroso; Luís Cláudio Lima de Jesus; Tales Fernando da Silva; Viviane Lima Batista; Juliana Laguna; Nina Dias Coelho-Rocha; Kátia Duarte Vital; Simone Odília Antunes Fernandes; Valbert Nascimento Cardoso; Enio Ferreira; Flaviano Santos Martins; Mariana Martins Drumond; Pamela Mancha-Agresti; Alexander Birbrair; Debmalya Barh; Vasco Azevedo
Journal:  Front Microbiol       Date:  2022-04-26       Impact factor: 6.064

3.  Lactobacillus reuteri HCM2 protects mice against Enterotoxigenic Escherichia coli through modulation of gut microbiota.

Authors:  Tianwei Wang; Kunling Teng; Gang Liu; Yayong Liu; Jie Zhang; Xin Zhang; Min Zhang; Yong Tao; Jin Zhong
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

Review 4.  What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing Research.

Authors:  Han-Yi Song; Long Zhou; Dong-Yan Liu; Xin-Jie Yao; Yan Li
Journal:  Gastroenterol Res Pract       Date:  2018-10-16       Impact factor: 2.260

5.  Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis.

Authors:  Xiaoguang Shi; Junhong Zhang; Lingshan Mo; Jialing Shi; Mengbin Qin; Xue Huang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Lactobacillus gasseri Suppresses the Production of Proinflammatory Cytokines in Helicobacter pylori-Infected Macrophages by Inhibiting the Expression of ADAM17.

Authors:  Hanna G Gebremariam; Khaleda Rahman Qazi; Tanvi Somiah; Sushil Kumar Pathak; Hong Sjölinder; Eva Sverremark Ekström; Ann-Beth Jonsson
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 7.  Maternal and early life exposures and their potential to influence development of the microbiome.

Authors:  Erin E Bolte; David Moorshead; Kjersti M Aagaard
Journal:  Genome Med       Date:  2022-01-11       Impact factor: 15.266

Review 8.  Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.

Authors:  Jianfu Ji; Hong Yang
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.